In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 2059-2062

  Noskin, Gary A ^a,b   Siddiqui, Farida ^a   Stosor, Valentina ^a   Hacek, Donna ^a   Peterson, Lance R ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TEICOPLANIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENCY; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0032819385     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.8.2059     Document Type: Article

References (15)

1. Bonten, M. J., M. K. Hayden, C. Nathan, T. W. Rice, and R. A. Weinstein. 1998. Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J. Infect. Dis. 177:378-382.
2. Bostic, G. D., M. B. Perri, L. A. Thal, and M. J. Zervos. 1998. Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multi-drug-resistant enterococci. Diagn. Microbiol. Infect. Dis. 30:109-112.
3. Daly, J. S., G. M. Eliopoulos, E. Reiszner, and R. C. Moellering, Jr. 1988. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds. J. Antimicrob. Chemother. 21:721-730.
4. Daly, J. S., G. M. Eliopoulos, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
5. Dembry, L. M., K. Uzokwe, and M. J. Zervos. 1996. Control of endemic glycopeptide-resistant enterococci. Infect. Control Hosp. Epidemiol. 17:286-292.
6. Dresser, L. D., and M. J. Rybak. 1998. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacotherapy 18:456-462.
7. Lin, A. H., R. W. Murray, T. J. Vidmar, and K. R. Marotti. 1997. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob. Agents Chemother. 41:2127-2131.
8. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. Document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
9. Noskin, G. A., F. Siddiqui, V. Stosor, J. Kruzynski, and L. R. Peterson. 1999. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin. Clin. Infect. Dis. 28:689-690.
10. Peterson, L. R., and C. J. Shanholtzer. 1992. Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin. Microbiol. Rev. 5:420-432.
11. Rybak, M. J., D. M. Cappelletty, T. Moldovan, J. R. Aeschlimann, and G. W. Kaatz. 1998. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium. Antimicrob. Agents Chemother. 42:721-724.
12. Schaadt, R. D., D. H. Batts, P. T. Daley-Yates, S. D. Pawsey, D. J. Stalker, and G. E. Zurenko. 1997. Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. Diagn. Microbiol. Infect. Dis. 28:201-204.
13. Schaberg, D. R. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91(Suppl. 3B):72S-75S.
14. Shinabarger, D. L., K. R. Marotti, R. W. Murray, A. H. Lin, E. P. Melchior, S. M. Swaney, D. S. Dunyak, W. F. Demyan, and J. M. Buysse. 1997. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob. Agents Chemother. 41:2132-2136.
15. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.